premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

COMMENT
Hello, I'm Michael O'Reilly-- Stockchase Research editor. This week we begin reporting "Stockchase Research Top Picks" and will do so every Tuesday and Thursday. These picks focus on newly released institutional analyst opinions and targets along with our own additional insights. Today's Top Picks focus on a Warren Buffet favorite, a defensive strategy and a household favorite. Enjoy!
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK

Stockchase Editor: Michael O'Reilly When Warren Buffet is a buyer, the market takes notice. He just purchased another $1.2 billion worth of shares at an average of around $24 over the past week. For arguably the strongest major US bank, BAC pays a good dividend that will certainly be sustainable, given only a 24% payout ratio. Analysts see over 15% upside in the share price. Knowing how the Oracle of Omaha invests, he might be targeting a return to even more lofty targets, near $36 -- the level it traded pre-pandemic. We also like the technical up trend of higher lows and would hold this unless it takes out key support around $22.50. Yield 2.85% (Analysts’ price target is $28.57)

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Editor: Michael O'Reilly With the general stock markets almost returning to pre-pandemic highs, analysts feel stocks are price near "perfection". This means that the market is at risk to sizable pullbacks if earnings and future growth prospects stumble. For income investors, HIU offers a way to confidently hold income producing assets, even in the face of significant market retracement. HIU is an inverse ETF of the S&P500 index that trades in Canadian dollars. Holding an asset that rises in value as the market erodes, creates a cash war chest that can be used to purchased undervalued assets later on. The added kicker is that the Canadian dollar will likely fall with the market, which will further add to the value of the ETF. A very defensive holding. Yield 0%
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

BUY ON WEAKNESS
Stockchase Editor: Michael O'Reilly Looking for yield can be challenging, but K is a company that is proving its worth during the pandemic. An obvious household name, it often gets over looked, but it is proving to be a survivor. The company just upgraded its annual sales and profit guidance for the year as organic net sales are up 9% on the quarter. EPS beat analyst expectations by 32%. We like the dividend and feel it is secure. We would look to enter on a pullback near $67 and use $62 as a stop loss. Yield 3.21%
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Editor: Michael O'Reilly GPC has increased its dividend for 63 consecutive years -- a real Dividend star. The company focuses on aftermarket and replacement car parts -- a rising trend given that new car sales are stagnating. Technically, the stock is riding an up trend with higher lows being made regularly. We would use $82 as a stop loss point and see an upside towards $115. We like the dividend and see it being stable. Yield 3.45%
COMMENT
Shares coming under pressure today due to drop in the US GDP. There's been a huge run up. US stimulus payments end today, and that's a challenge. People working from home, lower consumption of energy, and less restaurant traffic are taking a toll on the GDP.
COMMENT
Behaviour of US dollar related to recessions. Historically, the US dollar has been the standard for global transactions. But the Chinese yuan has taken a bite out of it. Plus fiscal policy has driven interest rates low. These elements are a structural bear on the dollar. The US doesn't have the healthy social safety net that its trading partners do. So the US will experience much deeper recessions than its partners. US dollar will continue to weaken if the full impact of Covid continues to affect the US.
COMMENT
Where to allocate capital? If currency were your only consideration, you'd redeem some of your US assets and put the money into areas like China, Hong Kong, and Singapore. Recovery in those markets will benefit you, and then you cycle back into the US when it falls to a low. Global investors cycle their money from strong currencies to weak.
COMMENT
What stocks on the Australian market can you recommend? BHP has done very, very well. Also South32. Also COH, one of the global leaders in hearing aids, though it's very expensive.
WAIT
This is an alpha vehicle. You buy it, hold it and trade it, then you sell it. Either short it, or hold it and expect a recovery. A lot of the potential for a US housing recovery at current interest rates is priced in. This is very volatile. Don't buy it when it's in the eighth month of a recovery cycle.
COMMENT
A CLO is an off-balance sheet vehicle. In 2008, they were problematic. BAC has exposure, and so they could pay off or they could become toxic. One reason to sell banks coming up to a recession and buy on recovery.
BUY
Great Canadian company. Impressive long-term chart. Long-term holders have been well rewarded. Balance sheet is a little leveraged. A liability with the US CCRA is due. Good scale, growth profile, and dividend. Will probably move forward after Covid. Good risk-adjusted return to buy and hold.
WEAK BUY
Relative to other large cap tech, hasn't seen the same upside. Relatively safe, value company. They're looking to transition to a more service type company. A great company, safe to hold, though there are better opportunities elsewhere.
WATCH
To sell or buy more depends on your gain so far. Canadian success story. Somewhat slow to acquire new assets. If you're value agnostic, it's a great company. If valuation is a concern, stay away from it. If the market moves higher, it will too. If there's a correction, it will suffer.
WATCH
The whole DNA area is very attractive. Many ways to play it. Category to pay attention to, but he prefers to play it through big pharma.